256 Newsroom — Uganda's Digital News Infrastructure
Business

Teva autoimmune antibody notches ph. 2 win in celiac disease - Fierce Biotech

Published by FierceBiotech By Darren Incorvaia · 2 September 2026 at 17:52
Share
Teva autoimmune antibody notches ph. 2 win in celiac disease - Fierce Biotech
Image · FierceBiotech

What the report says

Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive after the Israeli outfit’s anti-interleukin-15 antibody scored a

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Pearl Bank loan book crosses Shs 1 trillion milestoneThe Observer UBOS signs MoU with Bugwe, Adhola to strengthen community data collectionThe Observer 256 Newsroom URA extends offshore wealth amnesty: Why and who should care - Daily MonitorDaily Monitor 256 Newsroom Uganda, Nigeria pledge to seal delayed pact and lift trade as forum ends - PML DailyPML Daily Public barred from royal tombs as Tooro enforces strict burial protocols for King OyoThe Independent Uganda What Norway can teach Uganda’s Kingdoms about SuccessionNile Post